NASDAQ:RCEL Avita Medical (RCEL) Stock Price, News & Analysis $4.38 -0.15 (-3.31%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$4.54 +0.16 (+3.63%) As of 08/28/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avita Medical Stock (NASDAQ:RCEL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Avita Medical alerts:Sign Up Key Stats Today's Range$4.28▼$4.5850-Day Range$4.25▼$6.2652-Week Range$3.60▼$14.16Volume222,446 shsAverage Volume457,377 shsMarket Capitalization$116.60 millionP/E RatioN/ADividend YieldN/APrice Target$12.40Consensus RatingHold Company Overview AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California. Read More Avita Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreRCEL MarketRank™: Avita Medical scored higher than 31% of companies evaluated by MarketBeat, and ranked 811th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAvita Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAvita Medical has only been the subject of 3 research reports in the past 90 days.Read more about Avita Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avita Medical is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avita Medical is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Avita Medical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.71% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 16.6, which indicates bearish sentiment.Change versus previous monthShort interest in Avita Medical has recently increased by 1.93%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvita Medical does not currently pay a dividend.Dividend GrowthAvita Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted23.71% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 16.6, which indicates bearish sentiment.Change versus previous monthShort interest in Avita Medical has recently increased by 1.93%, indicating that investor sentiment is decreasing. News and Social Media2.4 / 5News Sentiment0.28 News SentimentAvita Medical has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Avita Medical this week, compared to 2 articles on an average week.Search Interest2 people have searched for RCEL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Avita Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $68,660.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.80% of the stock of Avita Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of Avita Medical is held by institutions.Read more about Avita Medical's insider trading history. Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCEL Stock News HeadlinesRobert Mcnamara Acquires 10,000 Shares of Avita Medical (NASDAQ:RCEL) StockAugust 21, 2025 | insidertrades.comAVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 28 at 3:41 PM | globenewswire.comINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world. | Traders Agency (Ad)AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the FirmAugust 27 at 4:02 PM | globenewswire.comAVITA Medical: Green Shoots Peaking Out From Hard ClayAugust 26 at 7:44 PM | seekingalpha.comKirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of InvestorsAugust 22, 2025 | globenewswire.comINVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLCAugust 22, 2025 | globenewswire.comAVITA Medical, Inc. (RCEL) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationAugust 21, 2025 | tmcnet.comSee More Headlines RCEL Stock Analysis - Frequently Asked Questions How have RCEL shares performed this year? Avita Medical's stock was trading at $12.80 at the start of the year. Since then, RCEL stock has decreased by 65.8% and is now trading at $4.38. How were Avita Medical's earnings last quarter? Avita Medical Inc. (NASDAQ:RCEL) released its quarterly earnings data on Thursday, August, 7th. The company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12. The firm earned $18.42 million during the quarter, compared to the consensus estimate of $34.27 million. Avita Medical had a negative net margin of 68.87% and a negative trailing twelve-month return on equity of 632.62%. Read the conference call transcript. Who are Avita Medical's major shareholders? Avita Medical's top institutional shareholders include Opaleye Management Inc. (1.46%), Jane Street Group LLC (0.33%), Marshall Wace LLP (0.29%) and Bank of America Corp DE (0.23%). Insiders that own company stock include Michael S Perry, Robert Mcnamara, Donna Shiroma, Suzanne Crowe, Jeremy Curnock Cook and James Corbett. View institutional ownership trends. How do I buy shares of Avita Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avita Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA). Company Calendar Last Earnings8/07/2025Today8/29/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:RCEL CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees130Year Founded2008Price Target and Rating Average Price Target for Avita Medical$12.40 High Price Target$21.00 Low Price Target$3.00 Potential Upside/Downside+183.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($1.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$61.85 million Net Margins-68.87% Pretax Margin-68.87% Return on Equity-632.62% Return on Assets-71.52% Debt Debt-to-Equity Ratio9.39 Current Ratio0.58 Quick Ratio0.46 Sales & Book Value Annual Sales$64.25 million Price / Sales1.81 Cash FlowN/A Price / Cash FlowN/A Book Value($0.48) per share Price / Book-9.13Miscellaneous Outstanding Shares26,620,000Free Float25,874,000Market Cap$116.60 million OptionableOptionable Beta1.63 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:RCEL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.